<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0040435" disease_type="Disease or Syndrome" abbrv="">Dental disorders</z:e> have been recognized as major sources of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (HM) </plain></SENT>
<SENT sid="1" pm="."><plain>Management of severe dental <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> usually includes dental extractions (DE), but the safety of extractions in patients with HM who are at risk for <z:mp ids='MP_0001914'>bleeding</z:mp>, <z:hpo ids='HP_0100806'>sepsis</z:hpo>, and <z:hpo ids='HP_0001058'>poor wound healing</z:hpo> has not been well established </plain></SENT>
<SENT sid="2" pm="."><plain>In conjunction with an aggressive program of dental care, 142 DE were performed in 26 patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, and <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001913'>Granulocytopenia</z:hpo> (less than 1,000 granulocytes/microL) was present during or within ten days following surgery in 14 patients </plain></SENT>
<SENT sid="4" pm="."><plain>In these 14 patients (101 DE), the mean granulocyte count was less than 450/microL, with a median duration of <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo> following surgery of 32 days (range, four to 169 days) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> (less than 100,000 platelets/microL) occurred during or within two days following surgery in 13 patients (80 DE), with a mean platelet count of 63,500/microL </plain></SENT>
<SENT sid="6" pm="."><plain>Transfusions were given for platelet counts less than 50,000/microL </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> DE were performed without significant complications </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> was minor to moderate and easily controlled with local measures; no patient required transfusion due to <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Average maximum temperature 24 hours after DE was 37.7 degrees C </plain></SENT>
<SENT sid="10" pm="."><plain>No episodes of <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e> were documented within ten days of DE </plain></SENT>
<SENT sid="11" pm="."><plain>Minor delay in wound healing was observed in two patients </plain></SENT>
<SENT sid="12" pm="."><plain>We conclude that DE can be safely performed in patients with HM in combination with aggressive supportive care </plain></SENT>
</text></document>